KKR & Co. (KKR) Appoints Oliver Johansen to its Board
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St slips on rising bond yields; Walmart results weigh
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
KKR Closes Acquisition of Clinisupplies and Welcomes Oliver Johansen to the Board of Directors
January 18, 2023 3:00 AM ESTKKR to support organic and inorganic growth to enhance Clinisupplies leadership position in collecting devices and expand its broader chronic care portfolio
 Oliver Johansen, former Senior Vice President, Global Research and Development at Coloplast, to join KKR Senior Advisor and former Chief Executive Officer of Atos Medical AB, Claus Bjerre, and industry veteran, Douglas Le Fort on Clinisupplies Board of Directors
LONDON--(BUSINESS WIRE)-- KKR, a leading global investment firm, announced today the closing of KKRs previously announced investment in Clinisupplies, a market leader in continence care products... More
